Ticker: BANB

Bachem

Data by iex cloud

Nov
05
2020
The Swiss Equity Conference

Bachem

The Swiss Equity Conference

Bachem

CEO Thomas Meier
CFO Stephan Schindler

ZKB Analyst: Michael Nawrath

Group meeting, One-on-one

Bachem, founded 1971 and operating worldwide, offers services for the pharma and biotech industry by manufacturing peptides and oligonucleotides as active pharmaceutical ingredients (APIs) and by providing innovative biochemicals for research. Bachem is the number one worldwide in the peptide business and can take profit from the more and more complex structures of molecules and new routes of administration developed for innovative targeted therapies.

Date & Location

05.11.2020
09:30 – 10:00

Zurich

Join event

Get first hand information about Switzerland's leading companies from their leaders themselves.

The following content is directed only to persons that meet below qualifications and have relevant professional experience and should not be acted on or relied on by other persons.

I'm acting for a legal entity with its registered office in:

which qualifies as institutional client according to Article 4(4) of the Federal Act on Financial Services (FinSA) or as a professional client according to Article 4(3) FinSA.

the legal entity is authorised by the PRA or FCA or qualifies as any other investment professional falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005

or the legal entity has a share capital or net assets of at least £5 million or qualifies for other grounds as a high net worth company according to Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005.

I am a natural person (retail client) or the company I'm acting for doesn't fit one of the categories above.

Confirm

Your web browser is out of date

Update your browser for more security, speed and the best experience.

Update my browser Continue

Need help?

Please contact

events@zkb.ch

or call +41 44 292 32 22